Exposure and food web transfer of pharmaceuticals in ospreys (Pandion haliaetus): Predictive model and empirical data
Open Access
- 1 August 2014
- journal article
- health and-ecological-risk-assessment
- Published by Oxford University Press (OUP) in Integrated Environmental Assessment and Management
- Vol. 11 (1) , 118-129
Abstract
The osprey (Pandion haliaetus) is a well-known sentinel of environmental contamination, yet no studies have traced pharmaceuticals through the water–fish–osprey food web. A screening-level exposure assessment was used to evaluate the bioaccumulation potential of 113 pharmaceuticals and metabolites, and an artificial sweetener in this food web. Hypothetical concentrations in water reflecting “wastewater effluent dominated” or “dilution dominated” scenarios were combined with pH-specific bioconcentration factors (BCFs) to predict uptake in fish. Residues in fish and osprey food intake rate were used to calculate the daily intake (DI) of compounds by an adult female osprey. Fourteen pharmaceuticals and a drug metabolite with a BCF greater than 100 and a DI greater than 20 µg/kg were identified as being most likely to exceed the adult human therapeutic dose (HTD). These 15 compounds were also evaluated in a 40 day cumulative dose exposure scenario using first-order kinetics to account for uptake and elimination. Assuming comparable absorption to humans, the half-lives (t1/2) for an adult osprey to reach the HTD within 40 days were calculated. For 3 of these pharmaceuticals, the estimated t1/2 in ospreys was less than that for humans, and thus an osprey might theoretically reach or exceed the HTD in 3 to 7 days. To complement the exposure model, 24 compounds were quantified in water, fish plasma, and osprey nestling plasma from 7 potentially impaired locations in Chesapeake Bay. Of the 18 analytes detected in water, 8 were found in fish plasma, but only 1 in osprey plasma (the antihypertensive diltiazem). Compared to diltiazem detection rate and concentrations in water (10/12 detects, Integr Environ Assess Manag 2015;11:118–129. © 2014 SETACKeywords
Funding Information
- USGS-Chesapeake Bay Program
- Texas Sea
This publication has 50 references indexed in Scilit:
- Assessing the exposure risk and impacts of pharmaceuticals in the environment on individuals and ecosystemsBiology Letters, 2013
- Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions?Environmental Health Perspectives, 2012
- Predicting the threats of chemicals to wildlife: What are the challenges?Integrated Environmental Assessment and Management, 2011
- Fate of Sucralose through Environmental and Water Treatment Processes and Impact on Plant Indicator SpeciesEnvironmental Science & Technology, 2011
- Summing nondetects: Incorporating low-level contaminants in risk assessmentIntegrated Environmental Assessment and Management, 2010
- Osprey Diet Composition and Quality in High- and Low- Salinity Areas of Lower Chesapeake BayJournal of Raptor Research, 2009
- Osprey: Worldwide Sentinel Species for Assessing and Monitoring Environmental Contamination in Rivers, Lakes, Reservoirs, and EstuariesJournal of Toxicology and Environmental Health, Part B, 2009
- DrugBank: a knowledgebase for drugs, drug actions and drug targetsNucleic Acids Research, 2007
- Determination of select antidepressants in fish from an effluent-dominated streamEnvironmental Toxicology and Chemistry, 2005
- Pharmacotherapeutic aspects of medication of birdsJournal of Veterinary Pharmacology and Therapeutics, 1988